Skip to main content

Table 1 Characteristics of the SQ®-HDM registered tablet [9]

From: New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets

Proteins from D. pteronissynus, percent

50%

Proteins from D. farinae, percent

50%

Proportion of group I/group II allergens

1/1

Der p 1 + Der p 2 content

15 µg

Der f 1 + Der f 2: content

15 µg

Formulation (orodispersible)

Zydis® technology

Time to full dissolution in oral cavity

3–4 s